Immuron
(NASDAQ:IMRN)
$2.09
0.09[4.50%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$1.85
-0.2400[-11.48%]
After Hours: 8:00AM EDT
Day Range1.97 - 2.0952 Wk Range- - 4.4Open / Close1.99 / 2.09Float / Outstanding- / 5.7M
Vol / Avg.2.1K / 2.6KMkt Cap11.9MP/E-50d Avg. Price1.89
Div / Yield-Payout Ratio-Total Float-EPS-

Immuron Stock (NASDAQ:IMRN), Quotes and News Summary

Immuron Stock (NASDAQ: IMRN) stock price, news, charts, stock research, profile.

Loading...
Day Range1.97 - 2.0952 Wk Range- - 4.4Open / Close1.99 / 2.09Float / Outstanding- / 5.7M
Vol / Avg.2.1K / 2.6KMkt Cap11.9MP/E-50d Avg. Price1.89
Div / Yield-Payout Ratio-Total Float-EPS-
Globe Newswire - Aug 19, 2022, 6:00AM
Globe Newswire - Apr 27, 2022, 6:00AM
Globe Newswire - Mar 16, 2022, 9:30AM
Globe Newswire - Jan 17, 2022, 6:00AM
Seeking Alpha - Aug 19, 2022, 6:33AM
Seeking Alpha - May 6, 2022, 5:16AM
InvestorsObserver - Jan 21, 2022, 12:50PM
InvestorsObserver - Jan 19, 2022, 5:58AM
InvestorsObserver - Jan 18, 2022, 6:15AM
InvestorsObserver - Jan 14, 2022, 6:26AM
Sector: Health Care.Industry: Biotechnology
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Earnings

see more
H1 2023Est.ActualSurprise
EPS
(EXPECTED)2022-12-13
REV
FY 2022Est.ActualSurprise
EPS-0.009
REV555.148K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Immuron (IMRN) stock?

A

You can purchase shares of Immuron (NASDAQ: IMRN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuron's (IMRN) competitors?

Q

What is the target price for Immuron (IMRN) stock?

A

The latest price target for Immuron (NASDAQ: IMRN) was reported by HC Wainwright & Co. on Wednesday, October 18, 2017. The analyst firm set a price target for 15.00 expecting IMRN to rise to within 12 months (a possible 617.70% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuron (IMRN)?

A

The stock price for Immuron (NASDAQ: IMRN) is $2.09 last updated Today at November 30, 2022, 8:45 PM UTC.

Q

Does Immuron (IMRN) pay a dividend?

A

There are no upcoming dividends for Immuron.

Q

When is Immuron (NASDAQ:IMRN) reporting earnings?

A

Immuron’s H1 earnings are confirmed for Tuesday, December 13, 2022.

Q

Is Immuron (IMRN) going to split?

A

There is no upcoming split for Immuron.

Q

What sector and industry does Immuron (IMRN) operate in?

A

Immuron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.